HER-2 and topo-isomerase IIα as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide
Titel:
HER-2 and topo-isomerase IIα as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide
Auteur:
Di Leo, A. Larsimont, D. Gancberg, D. Jarvinen, T. Beauduin, M. Vindevoghel, A. Michel, J. Focan, Ch. Ries, F. Gobert, Ph. Closon-Dejardin, M.-T. Dolci, S. Rouas, G. Paesmans, M. Lobelle, J.-P. Isola, J. Piccart, M.J.